Protein ubiquitination, a process that covalently conjugates ubiquitin to the lysine sites of a target protein, has emerged as a crucial regulatory mechanism in immune functions in mammals. E3 ubiquitin ligases determine the specificities of ubiquitination by recruiting substrate proteins. There are two main classes of E3 ligases: proteins with a catalytic domain that is homologous to the E6-AP carboxyl terminus (HECT) (19) and proteins with a RING (really interesting new gene) finger domain (20) . Several E3 ubiquitin ligases have been shown to have important roles in T-cell activation and anergy induction (32); (24). The RING-type E3 ubiquitin ligase, Cbl, Cbl-b and GRAIL, and the HECT-type E3 ligases, Itch and NEDD4, have been identified as important regulators of T-cell development, activation, differentiation and tolerance (1, 2, 5, 12, 18, 33) . AIP2, also known as WW domain-containing protein 2 (WWP2), is a member of atrophin-interaction protein (AIP) family (41). AIP family members are characterized by the presence of a catalytic HECT domain that facilitates ubiquitin ligation to substrate proteins. In addition, members of this family of E3 ligases contain multiple WW domains that mediate binding to PPxY motifs, and an NH2-terminal C2 domain (calcium/lipid binding) that may be important for the protein subcellular localization (27). AIP2 is widely expressed in most of the tissues and organs of both humans and mice (29), (3). The physiological functions of AIP2 are largely unknown. Several in vitro studies have suggested that AIP2 is involved in down-regulating epithelial sodium channels by directly targeting all three subunits of the sodium channel for ubiquitination (36). AIP2 is also one of the host factors that regulates the budding process of retroviruses (28). Recently, Xu et al. reported that AIP2 is an E3 ubiquitin ligase of the transcription factor Oct-4. Thus, AIP2 may be involved in embryonic development functioning to degrade Oct-4 via the ubiquitin pathway (43).
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AIP2, also known as WW domain-containing protein 2 (WWP2), is a member of atrophin-interaction protein (AIP) family (41) . AIP family members are characterized by the presence of a catalytic HECT domain that facilitates ubiquitin ligation to substrate proteins. In addition, members of this family of E3 ligases contain multiple WW domains that mediate binding to PPxY motifs, and an NH2-terminal C2 domain (calcium/lipid binding) that may be important for the protein subcellular localization (27) . AIP2 is widely expressed in most of the tissues and organs of both humans and mice (29) , (3) . The physiological functions of AIP2 are largely unknown. Several in vitro studies have suggested that AIP2 is involved in down-regulating epithelial sodium channels by directly targeting all three subunits of the sodium channel for ubiquitination (36) . AIP2 is also one of the host factors that regulates the budding process of retroviruses (28) . Recently, Xu et al. reported that AIP2 is an E3 ubiquitin ligase of the transcription factor Oct-4. Thus, AIP2 may be involved in embryonic development functioning to degrade Oct-4 via the ubiquitin pathway (43) .
EGR2, a member of the early growth response (EGR) protein family, has been isolated as a transcription factor (4, 21, 23, 41, 42) . A hallmark of the EGR family of transcription factors is a DNAbinding domain consisting of three cys2his2 zinc-finger motifs (21, 23) . This domain is known to bind the sequence GCGGGGCG. There are four members of egr family genes: EGR1 (Krox24, NGFI-A), EGR2 (Krox20), EGR3 (PILOT) and EGR4 (NGFI-C) (34) . EGR2 has been most widely studied in the context of the nervous system, and targeted mutation in mice results in early lethality concurrent to defects in hindbrain patterning, peripheral nerve myelination, and bone formation (15) . It has been shown that EGR2 transactivation is dependent on members of the NFAT family in T lymphocytes (35) . Recent studies demonstrated that EGR2 is one of the key negative regulators of T-cell activation, activation-induced apoptosis, and is involved in T-cell anergy induction (17, 37) .
Here we report that AIP2 positively regulates the activation of T cells by suppressing activationinduced apoptosis. AIP2 promotes EGR2 degradation and inhibits EGR2-driven FasL expression in T supplemented with 10% FBS (fetal bovine serum), 100U /ml penicillin, 200ug/ml streptomycin, and 0.25 µg/ml amphotericin B. Polyclonal antibodies against AIP2 or the epitope tag, HA (hemagglutinin), were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-CD3 and anti-CD28 were from eBioscience (San Diego, CA). The anti-Actin and anti-Flag antibodies were from Sigma (Sigma, St.
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Louis, MO). Anti-EGR2 antibody was from Covance (Covance, Princeton, NJ). Anti-ubiquitin antibody was purchased from Boston Biochem Inc (Boston, MA).
Plasmids An HA-tagged ubiquitin expression plasmid was used as reported previously (13) . Fulllength human AIP2 expression plasmid was a kind gift from Paul Bieniasz (The Rockefeller University) (28) . To generate truncated mutants, fragments of the AIP2 cDNA were amplified by PCR using linker primers that introduced an EcoRI site at 5'end and an XbaI site at 3' end. PCR products were digested with EcoRI and XbaI, and ligated into the pEFmyc/hisB expression vector (Invitrogen). The EGR2 expression plasmid is a generous gift from Jeffrey Milbrandt (Washington University) (6) . Point mutations were generated by PCR. AIP2 siRNA expression plasmids were generated by subcloning AIP2 fragments (FIG. 6A) into pLentilox 3.7 plasmids. All the newly generated plasmids in this study were verified by DNA sequencing.
Isolating mouse primary T cells and retroviral infection. T cells were isolated from the lymph nodes
and spleens of 4-6-week-old C57BL6 mice. All mice were maintained under specific pathogen-free conditions at the University of Missouri (Columbia, MO), and all animals were used in accordance with the strict guidelines of the institutional animal care committee. CD4+ T cells were purified by negative selection with the CD4+ T cell isolation kit (Miltenyi Biotec, Auburn, CA). These cells were maintained in RPMI media (Invitrogen Life Technologies, San Diego, CA) supplemented with 10% FBS, 100U /ml penicillin, 200ug/ml streptomycin, and 0.25ug/ml amphotericin, and stimulated anti-CD3 plus anti-CD28 (5 µg/ml each) for 24 hours before infection. Retrovirus were prepared by transfection of pMIG-AIP2 into the packaging cells, PlatE, as described (31) . Supernatants were used for the infection of pre-activated CD4+ T cells. During infection, polybrene (10 µg/ml), anti-CD3, anti-CD28 and IL-2 (20 U/ml) were added. Two days after infection, GFP + cells were sorted and used for analysis.
T-cell proliferation assay and IL-2 production. Mouse primary T cells (1X10 5 cells in 300 µl/well)
were stimulated with anti-CD3 or anti-CD3 plus anti-CD28 for 48hrs. 100 µl supernatants from each well VO 4 , and 10 µg/ml each of aprotinin and leupeptin). Cells were lyzed for 10 min at 4 °C, and insoluble materials were removed by centrifugation at 15,000 × g (4 °C, 10 min). For immunoprecipitation, lysates (~1 × 10 7 cells) were mixed with antibodies (1 µg) for 2 h, followed by the addition of 30 µl of protein G-Sepharose beads (Santa Cruz Biotechnology) for an additional 2 h at 4 °C.
Immunoprecipitates were washed four times with Nonidet P-40 lysis buffer and boiled in 20 µl of 2X
Laemmli's buffer. Samples were subjected to 8% or 10% SDS-polyacrylamide gel electrophoresis analysis and electrotransferred onto polyvinylidene difluoride membranes (Millipore). Membranes were probed with the indicated primary antibodies (usually 1 µg/ml), followed by horseradish peroxidase-conjugated secondary antibodies. Membranes were then washed and visualized with an enhanced chemiluminescence detection system (ECL; Amersham Pharmacia Biotech). When necessary, membranes were stripped by incubation in stripping buffer (62.5 mM Tris-HCl, pH 5.7, 100 mM 2-mercaptoethanol, and 2% SDS) for 6
In vitro protein-protein interaction assay. The cDNA fragment corresponding to four WW domains of AIP2 (amino acid 281-500) was subcloned into pGEX-6P GST-fusion protein expression vector and transformed into E coli BL21 (Invitrogen). GST-AIP2 WW protein in the lysates of bacteria was purified using glutathione agarose beads (Sigma). Similarly, EGR2 cDNA was subcloned into a His-tagged protein expression plasmid, pET-28a(+), and His-EGR2 fusion protein was purified using His-beads.
Purified proteins were mixed in binding buffer (250 mM NaCl, 10 mM Tris, pH 7.5, 1 mM DTT) at 5µg/ml each and incubated for 1 hour on ice followed by adding GST-beads for an additional 30 minute incubation. Beads were then washed three times with binding buffer and subjected to SDS-PAGE and western blotting analysis.
RESULTS
AIP2 enhances the activation of mouse primary T cells.
We have previously demonstrated that Itch, a HECT-type E3 ubiquitin ligase, is a negative regulator of T-cell activation and Th2 differentiation (10).
To determine the involvement of the HECT-type E3 ligases in T-cell functions, we investigated the effects of seven HECT-type E3 ligases on the activation of mouse primary T cells. We found that ectopic A previous report indicated that AIP2 is highly-expressed in mouse spleen as demonstrated by
Northern blotting (43) . Here we further analyzed the expression patterns of AIP2 in mouse immune tissues, including bone marrow, thymus, spleen and lymph nodes by western blotting. AIP2 protein was detected at very low levels in mouse bone marrow, while it is highly-expressed in thymus, spleen and lymph nodes (data not shown). AIP2 is also highly expressed in naïve CD4+ T cells. Stimulation of those T cells with anti-CD3 or anti-CD28 did not significantly induce AIP2 expression (data not shown). These results indicate that AIP2 is well-expressed in mouse immune tissues and T cells, suggesting that AIP2 may be involved in the regulation of the immune functions in mice.
AIP2 interacts with and promotes ubiquitination of EGR2 in vitro.
To determine the molecular mechanisms of AIP2 in regulating T-cell activation, we used a yeast two-hybrid screening approach to 3A) . Together with our findings that AIP2 interacts with EGR2 (FIG. 2) , these results suggest that AIP2 is an E3 ubiquitin ligase of EGR2.
The interaction of an E3 ubiquitin ligase with its substrate proteins, either direct or indirect, is required for ubiquitin conjugation (13) . We next tested whether the mutation of these two PPxY motifs of EGR2, which abolished its interaction with AIP2, affected AIP2-mediated ubiquitination. As shown in FIG. 3B , AIP2 overexpression significantly enhanced EGR2 ubiquitination, but its overexpression failed to promote ubiquitin conjugation onto the EGR2/YF mutant, indicating the interaction between AIP2 and EGR2 is required for AIP2-mediated EGR2 ubiquitination.
The HECT domain has been demonstrated to harbor E3 ligase activity, which recruits ubiquitincarrying E2s and transfers ubiquitin to the lysine sites of a substrate protein (19) . We thus tested whether the HECT domain of AIP2 is required for EGR2 ubiquitination. Deletion of the HECT domain of AIP2 completely abolished its ability to promote EGR2 ubiquitination (FIG. 3C) , while the interaction of AIP2
with EGR2 was not affected by deletion of the HECT domain (FIG. 3D) . Thus, AIP2-mediated EGR2 ubiquitination requires the HECT E3 ligase domain.
Since activation signal-mediated by TCR/CD28 stimuli facilitate AIP2/EGR2 interaction in T cells (FIG. FIG. 2D ), we then asked whether EGR2 ubiquitination is increased in activated T cells. Indeed, anti-CD3 plus anti-CD28 stimulation significantly enhanced EGR2 ubiquitination, while TCR stimulation alone has modest effects (FIG. 3E) . Therefore, AIP2-mediated EGR2 ubiquitination is regulated by T cell activation signals. To test whether AIP2 enhances T-cell activation by promoting EGR2 degradation, we determined the protein expression levels of EGR2 in mouse primary T cells when AIP2 is over-expressed. FIG. 4D shows that protein levels of EGR2 were dramatically reduced in T cells in which AIP2 was overexpressed, suggesting that AIP2 down-regulates EGR2 expression. Protein expression can be regulated at both mRNA and post-translational levels. To further investigate the molecular mechanisms underlying AIP2 suppression of EGR2 expression, we examined whether expression of AIP2 affects EGR2 mRNA levels. As shown in FIG. 4E , mRNA levels were not changed in those T cells in which AIP2 was overexpressed when compared to its levels in T cells infected with control virus, suggesting that AIP2 inhibits EGR2 expression at the posttranslational level in T cells. To support this, we further demonstrated that AIP2 expression enhanced EGR2 ubiquitination in T cells (FIG. 4F) .
AIP2 inhibits FasL expression in T cells. Studies have demonstrated that EGR2 regulates activation-
induced T cell death by promoting FasL expression (7-9, 30, 35, 44, 45) . Together with our findings here that AIP2 expression inhibits T-cell apoptosis and promotes EGR2 degradation, we hypothesized that increased EGR2 protein levels in T cells. As a control, Actin protein levels were not affected by AIP2
siRNA (FIG. 6B) . This increased EGR2 protein levels by AIP2 suppression is due to the reduced EGR2 ubiquitination (FIG. 6C) . Together with our findings that AIP2 overexpression induces EGR2 ubiquitination and promotes EGR2 degradation (Figs. 3&4) , we conclude that AIP2 E3 ubiquitin ligase is responsible for EGR2 protein degradation in T cells. Together with the finding of increased EGR2 expression in AIP2 knockdown T cells, these results suggest that AIP2 suppress EGR2-mediated Cbl-b transcription.
DISCUSSION
In this report, we have found that the E3 ubiquitin ligase AIP2 facilitates T cell activation and inhibits activation-induced T cell apoptosis. AIP2 suppresses T cell apoptosis by promoting the degradation of EGR2, a transcription factor that is responsible for FasL expression. These findings uncovered a previously uncharacterized mechanism underlying AIP2 in regulation of T cell function in mammals.
Activation-induced cell death is one crucial mechanism that maintains homeostasis in the peripheral lymphoid tissues after clonal expansion. Fas and Fas ligand-mediated apoptosis play an important role in deleting clonally expanded T cells that are no longer useful (16) . Mice-deficient in Fas or FasL show defects in peripheral T cell deletion and eventually develop autoimmune disorders (40) . Several transcription factors, including NFAT, AP-1, NF-kB and EGR family proteins, have been found to regulate the expression of FasL during activation-induced death of T cells (22, 25, 39) . Our studies here demonstrate that AIP2 regulates FasL expression by catalyzing EGR2 for ubiquitination and degradation, which defines a new mechanism in regulating activation-induced T cell death. EGR2 functions as a negative regulator for T cell activation by transcription of both FasL and the E3 ubiquitin ligase Cbl-b (37). Indeed, AIP2 appears to promote T cell activation by down-regulating the transcription of EGR2 target genes, both FasL and Cbl-b, and may be others.
EGR2 was initially identified as a protein with three zinc fingers, whose expression is activated during G0/G1 transition in cultured cells (4) . Recent studies have demonstrated that EGR2 regulates activationinduced T cell death by promoting FasL expression (7-9, 30, 35, 44, 45) . In addition, EGR2 regulates the development and activation of T lymphocytes in mice (32) . The expression of EGR2 is highly 
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